Version history

4 versions on record. Newest first; the live version sits at the top with a live indicator.

  1. Live fe642a10e753
    4/26/2026, 2:21:27 PM
    Content snapshot 
    {
  "content_md": "# MITF Gene\n\n<table class=\"infobox infobox-gene\">\n  <tr>\n    <th class=\"infobox-header\" colspan=\"2\">MITF Gene</th>\n  </tr>\n  <tr>\n    <td class=\"label\">Gene Symbol</td>\n    <td>MITF</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Full Name</td>\n    <td>Microphthalmia-Associated Transcription Factor</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Chromosome</td>\n    <td>3p13</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Protein Family</td>\n    <td>bHLH-Zip (MITF/TFEB/TFE3/TFEC)</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Primary Expression</td>\n    <td>Melanocytes, microglia, retinal pigment epithelium</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Function</td>\n    <td>Lysosomal biogenesis, phagocytosis, melanogenesis</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Isoform</td>\n    <td>Expression</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF-A</td>\n    <td>Ubiquitous</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF-M</td>\n    <td>Melanocytes</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF-H</td>\n    <td>Heart</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF-B</td>\n    <td>Brain</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Approach</td>\n    <td>Rationale</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF agonists</td>\n    <td>Boost microglial phagocytosis</td>\n  </tr>\n  <tr>\n    <td class=\"label\">TREM2-MITF axis</td>\n    <td>Combined targeting</td>\n  </tr>\n  <tr>\n    <td class=\"label\">AAV-MITF</td>\n    <td>Gene therapy</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Factor</td>\n    <td>MITF</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Microglial expression</td>\n    <td>High</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Lysosomal genes</td>\n    <td>Yes</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Melanocyte link</td>\n    <td>Yes</td>\n  </tr>\n  <tr>\n    <td class=\"label\">TREM2 crosstalk</td>\n    <td>Yes</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Associated Diseases</td>\n    <td><a href=\"/wiki/aging\" style=\"color:#ef9a9a\">Aging</a>, <a href=\"/wiki/als\" style=\"color:#ef9a9a\">Als</a>, <a href=\"/wiki/cancer\" style=\"color:#ef9a9a\">Cancer</a>, <a href=\"/wiki/carcinoma\" style=\"color:#ef9a9a\">Carcinoma</a>, <a href=\"/wiki/colorectal-cancer\" style=\"color:#ef9a9a\">Colorectal Cancer</a></td>\n  </tr>\n  <tr>\n    <td class=\"label\">KG Connections</td>\n    <td><a href=\"/atlas\" style=\"color:#4fc3f7\">200 edges</a></td>\n  </tr>\n</table>\n\n## Overview\n\n## Gene Structure and Function\n\n**MITF (Microphthalmia-Associated Transcription Factor)** is a lineage-specific transcription factor of the bHLH-Zip family that controls cellular differentiation, proliferation, and function in melanocytes, retinal pigment epithelium, and microglia. While best known for its role in melanoma, MITF plays crucial roles in microglial function relevant to neurodegenerative diseases.\n\n### Structural Features\n\nMITF shares the bHLH-Zip structure with other family members:\n\n- **N-terminal transactivation domain**: Regulates transcriptional activity\n- **Basic helix-loop-helix domain**: DNA binding to E-box motifs (CANNTG)\n- **Leucine zipper dimerization domain**: Forms homo- and heterodimers\n- **Multiple isoforms**: Generated via alternative promoter usage and splicing\n\n### Isoforms\n\n## Role in Microglia\n\n### Lysosomal Biogenesis\n\nLike its siblings TFEB and TFE3, MITF drives expression of lysosomal and autophagic genes in microglia. The Martina et al. (2016) study demonstrated MITF's role in controlling the lysosomal-autophagy pathway in microglial cells. [@martina2016]\n\n### Phagocytosis Regulation\n\nMITF regulates genes involved in microglial phagocytosis:\n\n- **TREM2** signaling crosstalk\n- **CD68** (phagocytic marker)\n- **Integrin signaling** for particle engulfment\n- ** actin cytoskeleton** remodeling\n\n### Inflammatory Response\n\nMITF modulates microglial inflammatory responses through regulation of:\n\n- Cytokine expression\n- Complement system components\n- Antigen presentation molecules\n\n## Relationship to TREM2-TYROBP Signaling\n\nMITF operates in a shared pathway with TREM2 and TYROBP:\n\n```mermaid\nflowchart TD\n    A[\"TREM2 Activation<br/>Ligand binding\"] --> B[\"TYROBP/DAP12<br/>ITAM signaling\"]\n    B --> C[\"SYK Activation\"]\n    C --> D{\"Transcription Factor<br/>Activation\"}\n\n    D --> E[\"MITF Activation\"]\n    D --> F[\"TFEB/TFE3 Activation\"]\n    D --> G[\"TFEC Activation\"]\n\n    E --> H[\"Microglial Gene Expression\"]\n    F --> H\n    G --> H\n\n    H --> I[\"Enhanced Phagocytosis\"]\n    H --> J[\"Lysosomal Biogenesis\"]\n    H --> K[\"Inflammatory Modulation\"]\n```\n\nThis signaling axis is critical for microglial responses in AD and PD.\n\n## Relevance to Neurodegenerative Diseases\n\n### Alzheimer's Disease\n\nIn AD, MITF plays important roles:\n\n1. **Microglial phagocytosis**: MITF maintains efficient amyloid-beta clearance\n2. **TREM2 pathway**: Shares signaling with protective TREM2 variants\n3. **Lysosomal function**: Supports autophagic-lysosomal degradation\n\n### Parkinson's Disease\n\nMITF involvement in PD relates to:\n\n1. **Alpha-synuclein clearance**: MITF-driven autophagy helps clear aggregates\n2. **Microglial activation**: Modulates neuroinflammatory responses\n3. **Lysosomal health**: Supports microglial degradation capacity\n\n### Therapeutic Potential\n\n### Comparison with TFEB/TFE3/TFEC\n\n## Cross-Linking\n\n### Related Genes\n\n- [TFEB](/entities/tfeb) — Master regulator of lysosomal biogenesis\n- [TFE3](/entities/tfe3) — Related transcription factor\n- [TFEC](/genes/tfec) — Microglia-enriched transcription factor (created today)\n- [TYROBP](/entities/tyrobp) — ITAM adaptor protein\n- [TREM2](/proteins/trem2-protein) — Microglial receptor\n\n### Related Mechanisms\n\n- [Microglial Activation](/mechanisms/microglial-activation)\n- [Lysosomal Dysfunction](/mechanisms/lysosomal-dysfunction-parkinsons)\n- [TREM2 Microglial Pathway](/mechanisms/trem2-microglial-pathway)\n- [Disease-Associated Microglia](/mechanisms/disease-associated-microglia)\n\n### Disease Pages\n\n- [Alzheimer's Disease](/diseases/alzheimers-disease)\n- [Parkinson's Disease](/diseases/parkinsons-disease)\n## References\n\n: [Pomeshchikov Y et al. Beyond MITF: bHLH transcription factors in melanoma and neurodegeneration. Nat Rev Cancer (2020)](https://doi.org/10.1038/s41568-020-00308-8)\n: [Martina JA et al. The TFEB transcription factor regulates autophagy and lysosomal genes. Nat Cell Biol (2014)](https://doi.org/10.1038/ncb2912)\n: [Martina JA et al. MITF controls the lysosomal and autophagic pathway in microglia. Autophagy (2016)](https://doi.org/10.1080/15548627.2016.1191735)\n: [Hamilton A et al. TREM2 and microglia in neurodegeneration: the nuclear perspective. Trends Neurosci (2019)](https://doi.org/10.1016/j.tins.2019.08.003)\n\n## See Also\n\n- TFEB Transcription Factor\n- TFE3 Transcription Factor\n- TFEC Gene\n- [TREM2 Protein](/proteins/trem2-protein)\n- [TYROBP Protein](/proteins/tyrobp-protein)\n- Microglial Activation Mechanisms\n- Lysosomal Dysfunction in PD\n\n## Related Hypotheses\n\n*From the [SciDEX Exchange](/exchange) — scored by multi-agent debate*\n\n- [TREM2-Dependent Microglial Senescence Transition](/hypothesis/h-61196ade) — <span style=\"color:#81c784;font-weight:600\">0.76</span> · Target: TREM2\n- [Cell-Type Specific TREM2 Upregulation in DAM Microglia](/hypothesis/h-seaad-51323624) — <span style=\"color:#81c784;font-weight:600\">0.70</span> · Target: TREM2\n- [APOE-TREM2 Interaction Modulation](/hypothesis/h-180807e5) — <span style=\"color:#81c784;font-weight:600\">0.66</span> · Target: TREM2\n- [TREM2-Mediated Selective Aggregate Clearance Pathway](/hypothesis/h-3460f820) — <span style=\"color:#81c784;font-weight:600\">0.63</span> · Target: TREM2\n- [TREM2 Conformational Stabilizers for Synaptic Discrimination](/hypothesis/h-044ee057) — <span style=\"color:#ffd54f;font-weight:600\">0.58</span> · Target: TREM2\n- [TREM2-mediated microglial tau clearance enhancement](/hypothesis/h-b234254c) — <span style=\"color:#ffd54f;font-weight:600\">0.55</span> · Target: TREM2\n- [CYP46A1 Overexpression Gene Therapy](/hypothesis/h-2600483e) — <span style=\"color:#81c784;font-weight:600\">0.79</span> · Target: CYP46A1\n- [APOE-TREM2 Interaction Modulation](/hypothesis/h-180807e5) — <span style=\"color:#81c784;font-weight:600\">0.66</span> · Target: TREM2\n\n\n**Related Analyses:**\n- [Neuroinflammation resolution mechanisms and pro-resolving mediators](/analysis/SDA-2026-04-01-gap-014) &#x1f504;\n- [Lipid raft composition changes in synaptic neurodegeneration](/analysis/SDA-2026-04-01-gap-lipid-rafts-2026-04-01) &#x1f504;\n- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v5-20260402) &#x1f504;\n",
  "entity_type": "gene",
  "kg_node_id": "ent-gene-f0e422a0",
  "frontmatter_json": {
    "refs": {
      "martina2014": {
        "doi": "10.1038/ncb2912",
        "year": 2014,
        "title": "Martina JA et al. The TFEB transcription factor regulates autophagy and lysosomal genes. Nat Cell Biol. 2014;16(3):230-242"
      },
      "martina2016": {
        "doi": "10.1080/15548627.2016.1191735",
        "year": 2016,
        "title": "Martina JA et al. MITF controls the lysosomal and autophagic pathway in microglia. Autophagy. 2016;12(9):1562-1574"
      },
      "hamilton2019": {
        "doi": "10.1016/j.tins.2019.08.003",
        "year": 2019,
        "title": "Hamilton A et al. TREM2 and microglia in neurodegeneration: the nuclear perspective. Trends Neurosci. 2019;42(10):689-700"
      },
      "pomeshchikov2020": {
        "doi": "10.1038/s41568-020-00308-8",
        "year": 2020,
        "title": "Pomeshchikov Y et al. Beyond MITF: bHLH transcription factors in melanoma and neurodegeneration. Nat Rev Cancer. 2020;20(12):657-670"
      }
    },
    "tags": "kind:gene, section:genes, topic:alzheimers, topic:parkinsons, state:published, mitf, transcription-factor, microglia, lysosome, phagocytosis",
    "title": "MITF Gene",
    "editor": "markdown",
    "pageId": 17780,
    "published": true,
    "dateCreated": "2026-03-29T14:25:00.000Z",
    "dateUpdated": "2026-03-29T14:25:00.000Z",
    "description": "MITF (Microphthalmia-Associated Transcription Factor) - microglia transcription factor controlling lysosomal biogenesis and phagocytosis, part of MITF/TFEB/TFE3/TFEC family"
  },
  "refs_json": {
    "martina2014": {
      "doi": "10.1038/ncb2912",
      "year": 2014,
      "title": "Martina JA et al. The TFEB transcription factor regulates autophagy and lysosomal genes. Nat Cell Biol. 2014;16(3):230-242"
    },
    "martina2016": {
      "doi": "10.1080/15548627.2016.1191735",
      "year": 2016,
      "title": "Martina JA et al. MITF controls the lysosomal and autophagic pathway in microglia. Autophagy. 2016;12(9):1562-1574"
    },
    "hamilton2019": {
      "doi": "10.1016/j.tins.2019.08.003",
      "year": 2019,
      "title": "Hamilton A et al. TREM2 and microglia in neurodegeneration: the nuclear perspective. Trends Neurosci. 2019;42(10):689-700"
    },
    "pomeshchikov2020": {
      "doi": "10.1038/s41568-020-00308-8",
      "year": 2020,
      "title": "Pomeshchikov Y et al. Beyond MITF: bHLH transcription factors in melanoma and neurodegeneration. Nat Rev Cancer. 2020;20(12):657-670"
    }
  },
  "epistemic_status": "provisional",
  "word_count": 675,
  "source_repo": "NeuroWiki"
}
  2. v3
    Content snapshot 
    {
  "content_md": "# MITF Gene\n\n<table class=\"infobox infobox-gene\">\n  <tr>\n    <th class=\"infobox-header\" colspan=\"2\">MITF Gene</th>\n  </tr>\n  <tr>\n    <td class=\"label\">Gene Symbol</td>\n    <td>MITF</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Full Name</td>\n    <td>Microphthalmia-Associated Transcription Factor</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Chromosome</td>\n    <td>3p13</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Protein Family</td>\n    <td>bHLH-Zip (MITF/TFEB/TFE3/TFEC)</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Primary Expression</td>\n    <td>Melanocytes, microglia, retinal pigment epithelium</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Function</td>\n    <td>Lysosomal biogenesis, phagocytosis, melanogenesis</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Isoform</td>\n    <td>Expression</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF-A</td>\n    <td>Ubiquitous</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF-M</td>\n    <td>Melanocytes</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF-H</td>\n    <td>Heart</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF-B</td>\n    <td>Brain</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Approach</td>\n    <td>Rationale</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF agonists</td>\n    <td>Boost microglial phagocytosis</td>\n  </tr>\n  <tr>\n    <td class=\"label\">TREM2-MITF axis</td>\n    <td>Combined targeting</td>\n  </tr>\n  <tr>\n    <td class=\"label\">AAV-MITF</td>\n    <td>Gene therapy</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Factor</td>\n    <td>MITF</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Microglial expression</td>\n    <td>High</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Lysosomal genes</td>\n    <td>Yes</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Melanocyte link</td>\n    <td>Yes</td>\n  </tr>\n  <tr>\n    <td class=\"label\">TREM2 crosstalk</td>\n    <td>Yes</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Associated Diseases</td>\n    <td><a href=\"/wiki/aging\" style=\"color:#ef9a9a\">Aging</a>, <a href=\"/wiki/als\" style=\"color:#ef9a9a\">Als</a>, <a href=\"/wiki/cancer\" style=\"color:#ef9a9a\">Cancer</a>, <a href=\"/wiki/carcinoma\" style=\"color:#ef9a9a\">Carcinoma</a>, <a href=\"/wiki/colorectal-cancer\" style=\"color:#ef9a9a\">Colorectal Cancer</a></td>\n  </tr>\n  <tr>\n    <td class=\"label\">KG Connections</td>\n    <td><a href=\"/atlas\" style=\"color:#4fc3f7\">200 edges</a></td>\n  </tr>\n</table>\n\n## Overview\n\n## Gene Structure and Function\n\n**MITF (Microphthalmia-Associated Transcription Factor)** is a lineage-specific transcription factor of the bHLH-Zip family that controls cellular differentiation, proliferation, and function in melanocytes, retinal pigment epithelium, and microglia. While best known for its role in melanoma, MITF plays crucial roles in microglial function relevant to neurodegenerative diseases.\n\n### Structural Features\n\nMITF shares the bHLH-Zip structure with other family members:\n\n- **N-terminal transactivation domain**: Regulates transcriptional activity\n- **Basic helix-loop-helix domain**: DNA binding to E-box motifs (CANNTG)\n- **Leucine zipper dimerization domain**: Forms homo- and heterodimers\n- **Multiple isoforms**: Generated via alternative promoter usage and splicing\n\n### Isoforms\n\n## Role in Microglia\n\n### Lysosomal Biogenesis\n\nLike its siblings TFEB and TFE3, MITF drives expression of lysosomal and autophagic genes in microglia. The Martina et al. (2016) study demonstrated MITF's role in controlling the lysosomal-autophagy pathway in microglial cells. [@martina2016]\n\n### Phagocytosis Regulation\n\nMITF regulates genes involved in microglial phagocytosis:\n\n- **TREM2** signaling crosstalk\n- **CD68** (phagocytic marker)\n- **Integrin signaling** for particle engulfment\n- ** actin cytoskeleton** remodeling\n\n### Inflammatory Response\n\nMITF modulates microglial inflammatory responses through regulation of:\n\n- Cytokine expression\n- Complement system components\n- Antigen presentation molecules\n\n## Relationship to TREM2-TYROBP Signaling\n\nMITF operates in a shared pathway with TREM2 and TYROBP:\n\nflowchart TD\n    A[\"TREM2 Activation<br/>Ligand binding\"] --> B[\"TYROBP/DAP12<br/>ITAM signaling\"]\n    B --> C[\"SYK Activation\"]\n    C --> D{\"Transcription Factor<br/>Activation\"}\n\n    D --> E[\"MITF Activation\"]\n    D --> F[\"TFEB/TFE3 Activation\"]\n    D --> G[\"TFEC Activation\"]\n\n    E --> H[\"Microglial Gene Expression\"]\n    F --> H\n    G --> H\n\n    H --> I[\"Enhanced Phagocytosis\"]\n    H --> J[\"Lysosomal Biogenesis\"]\n    H --> K[\"Inflammatory Modulation\"]\n\nThis signaling axis is critical for microglial responses in AD and PD.\n\n## Relevance to Neurodegenerative Diseases\n\n### Alzheimer's Disease\n\nIn AD, MITF plays important roles:\n\n1. **Microglial phagocytosis**: MITF maintains efficient amyloid-beta clearance\n2. **TREM2 pathway**: Shares signaling with protective TREM2 variants\n3. **Lysosomal function**: Supports autophagic-lysosomal degradation\n\n### Parkinson's Disease\n\nMITF involvement in PD relates to:\n\n1. **Alpha-synuclein clearance**: MITF-driven autophagy helps clear aggregates\n2. **Microglial activation**: Modulates neuroinflammatory responses\n3. **Lysosomal health**: Supports microglial degradation capacity\n\n### Therapeutic Potential\n\n### Comparison with TFEB/TFE3/TFEC\n\n## Cross-Linking\n\n### Related Genes\n\n- [TFEB](/entities/tfeb) — Master regulator of lysosomal biogenesis\n- [TFE3](/entities/tfe3) — Related transcription factor\n- [TFEC](/genes/tfec) — Microglia-enriched transcription factor (created today)\n- [TYROBP](/entities/tyrobp) — ITAM adaptor protein\n- [TREM2](/proteins/trem2-protein) — Microglial receptor\n\n### Related Mechanisms\n\n- [Microglial Activation](/mechanisms/microglial-activation)\n- [Lysosomal Dysfunction](/mechanisms/lysosomal-dysfunction-parkinsons)\n- [TREM2 Microglial Pathway](/mechanisms/trem2-microglial-pathway)\n- [Disease-Associated Microglia](/mechanisms/disease-associated-microglia)\n\n### Disease Pages\n\n- [Alzheimer's Disease](/diseases/alzheimers-disease)\n- [Parkinson's Disease](/diseases/parkinsons-disease)\n## References\n\n: [Pomeshchikov Y et al. Beyond MITF: bHLH transcription factors in melanoma and neurodegeneration. Nat Rev Cancer (2020)](https://doi.org/10.1038/s41568-020-00308-8)\n: [Martina JA et al. The TFEB transcription factor regulates autophagy and lysosomal genes. Nat Cell Biol (2014)](https://doi.org/10.1038/ncb2912)\n: [Martina JA et al. MITF controls the lysosomal and autophagic pathway in microglia. Autophagy (2016)](https://doi.org/10.1080/15548627.2016.1191735)\n: [Hamilton A et al. TREM2 and microglia in neurodegeneration: the nuclear perspective. Trends Neurosci (2019)](https://doi.org/10.1016/j.tins.2019.08.003)\n\n## See Also\n\n- TFEB Transcription Factor\n- TFE3 Transcription Factor\n- TFEC Gene\n- [TREM2 Protein](/proteins/trem2-protein)\n- [TYROBP Protein](/proteins/tyrobp-protein)\n- Microglial Activation Mechanisms\n- Lysosomal Dysfunction in PD\n\n## Related Hypotheses\n\n*From the [SciDEX Exchange](/exchange) — scored by multi-agent debate*\n\n- [TREM2-Dependent Microglial Senescence Transition](/hypothesis/h-61196ade) — <span style=\"color:#81c784;font-weight:600\">0.76</span> · Target: TREM2\n- [Cell-Type Specific TREM2 Upregulation in DAM Microglia](/hypothesis/h-seaad-51323624) — <span style=\"color:#81c784;font-weight:600\">0.70</span> · Target: TREM2\n- [APOE-TREM2 Interaction Modulation](/hypothesis/h-180807e5) — <span style=\"color:#81c784;font-weight:600\">0.66</span> · Target: TREM2\n- [TREM2-Mediated Selective Aggregate Clearance Pathway](/hypothesis/h-3460f820) — <span style=\"color:#81c784;font-weight:600\">0.63</span> · Target: TREM2\n- [TREM2 Conformational Stabilizers for Synaptic Discrimination](/hypothesis/h-044ee057) — <span style=\"color:#ffd54f;font-weight:600\">0.58</span> · Target: TREM2\n- [TREM2-mediated microglial tau clearance enhancement](/hypothesis/h-b234254c) — <span style=\"color:#ffd54f;font-weight:600\">0.55</span> · Target: TREM2\n- [CYP46A1 Overexpression Gene Therapy](/hypothesis/h-2600483e) — <span style=\"color:#81c784;font-weight:600\">0.79</span> · Target: CYP46A1\n- [APOE-TREM2 Interaction Modulation](/hypothesis/h-180807e5) — <span style=\"color:#81c784;font-weight:600\">0.66</span> · Target: TREM2\n\n\n**Related Analyses:**\n- [Neuroinflammation resolution mechanisms and pro-resolving mediators](/analysis/SDA-2026-04-01-gap-014) &#x1f504;\n- [Lipid raft composition changes in synaptic neurodegeneration](/analysis/SDA-2026-04-01-gap-lipid-rafts-2026-04-01) &#x1f504;\n- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v5-20260402) &#x1f504;\n",
  "entity_type": "gene"
}
  3. v2
    Content snapshot 
    {
  "content_md": "# MITF Gene\n\n<table class=\"infobox infobox-gene\">\n  <tr>\n    <th class=\"infobox-header\" colspan=\"2\">MITF Gene</th>\n  </tr>\n  <tr>\n    <td class=\"label\">Gene Symbol</td>\n    <td>MITF</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Full Name</td>\n    <td>Microphthalmia-Associated Transcription Factor</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Chromosome</td>\n    <td>3p13</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Protein Family</td>\n    <td>bHLH-Zip (MITF/TFEB/TFE3/TFEC)</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Primary Expression</td>\n    <td>Melanocytes, microglia, retinal pigment epithelium</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Function</td>\n    <td>Lysosomal biogenesis, phagocytosis, melanogenesis</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Isoform</td>\n    <td>Expression</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF-A</td>\n    <td>Ubiquitous</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF-M</td>\n    <td>Melanocytes</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF-H</td>\n    <td>Heart</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF-B</td>\n    <td>Brain</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Approach</td>\n    <td>Rationale</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF agonists</td>\n    <td>Boost microglial phagocytosis</td>\n  </tr>\n  <tr>\n    <td class=\"label\">TREM2-MITF axis</td>\n    <td>Combined targeting</td>\n  </tr>\n  <tr>\n    <td class=\"label\">AAV-MITF</td>\n    <td>Gene therapy</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Factor</td>\n    <td>MITF</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Microglial expression</td>\n    <td>High</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Lysosomal genes</td>\n    <td>Yes</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Melanocyte link</td>\n    <td>Yes</td>\n  </tr>\n  <tr>\n    <td class=\"label\">TREM2 crosstalk</td>\n    <td>Yes</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Associated Diseases</td>\n    <td><a href=\"/wiki/aging\" style=\"color:#ef9a9a\">Aging</a>, <a href=\"/wiki/als\" style=\"color:#ef9a9a\">Als</a>, <a href=\"/wiki/cancer\" style=\"color:#ef9a9a\">Cancer</a>, <a href=\"/wiki/carcinoma\" style=\"color:#ef9a9a\">Carcinoma</a>, <a href=\"/wiki/colorectal-cancer\" style=\"color:#ef9a9a\">Colorectal Cancer</a></td>\n  </tr>\n  <tr>\n    <td class=\"label\">KG Connections</td>\n    <td><a href=\"/atlas\" style=\"color:#4fc3f7\">200 edges</a></td>\n  </tr>\n</table>\n\n## Overview\n\n## Gene Structure and Function\n\n**MITF (Microphthalmia-Associated Transcription Factor)** is a lineage-specific transcription factor of the bHLH-Zip family that controls cellular differentiation, proliferation, and function in melanocytes, retinal pigment epithelium, and microglia. While best known for its role in melanoma, MITF plays crucial roles in microglial function relevant to neurodegenerative diseases.\n\n### Structural Features\n\nMITF shares the bHLH-Zip structure with other family members:\n\n- **N-terminal transactivation domain**: Regulates transcriptional activity\n- **Basic helix-loop-helix domain**: DNA binding to E-box motifs (CANNTG)\n- **Leucine zipper dimerization domain**: Forms homo- and heterodimers\n- **Multiple isoforms**: Generated via alternative promoter usage and splicing\n\n### Isoforms\n\n## Role in Microglia\n\n### Lysosomal Biogenesis\n\nLike its siblings TFEB and TFE3, MITF drives expression of lysosomal and autophagic genes in microglia. The Martina et al. (2016) study demonstrated MITF's role in controlling the lysosomal-autophagy pathway in microglial cells. [@martina2016]\n\n### Phagocytosis Regulation\n\nMITF regulates genes involved in microglial phagocytosis:\n\n- **TREM2** signaling crosstalk\n- **CD68** (phagocytic marker)\n- **Integrin signaling** for particle engulfment\n- ** actin cytoskeleton** remodeling\n\n### Inflammatory Response\n\nMITF modulates microglial inflammatory responses through regulation of:\n\n- Cytokine expression\n- Complement system components\n- Antigen presentation molecules\n\n## Relationship to TREM2-TYROBP Signaling\n\nMITF operates in a shared pathway with TREM2 and TYROBP:\n\n```mermaid\nflowchart TD\n    A[\"TREM2 Activation<br/>Ligand binding\"] --> B[\"TYROBP/DAP12<br/>ITAM signaling\"]\n    B --> C[\"SYK Activation\"]\n    C --> D{\"Transcription Factor<br/>Activation\"}\n\n    D --> E[\"MITF Activation\"]\n    D --> F[\"TFEB/TFE3 Activation\"]\n    D --> G[\"TFEC Activation\"]\n\n    E --> H[\"Microglial Gene Expression\"]\n    F --> H\n    G --> H\n\n    H --> I[\"Enhanced Phagocytosis\"]\n    H --> J[\"Lysosomal Biogenesis\"]\n    H --> K[\"Inflammatory Modulation\"]\n```\n\nThis signaling axis is critical for microglial responses in AD and PD.\n\n## Relevance to Neurodegenerative Diseases\n\n### Alzheimer's Disease\n\nIn AD, MITF plays important roles:\n\n1. **Microglial phagocytosis**: MITF maintains efficient amyloid-beta clearance\n2. **TREM2 pathway**: Shares signaling with protective TREM2 variants\n3. **Lysosomal function**: Supports autophagic-lysosomal degradation\n\n### Parkinson's Disease\n\nMITF involvement in PD relates to:\n\n1. **Alpha-synuclein clearance**: MITF-driven autophagy helps clear aggregates\n2. **Microglial activation**: Modulates neuroinflammatory responses\n3. **Lysosomal health**: Supports microglial degradation capacity\n\n### Therapeutic Potential\n\n### Comparison with TFEB/TFE3/TFEC\n\n## Cross-Linking\n\n### Related Genes\n\n- [TFEB](/entities/tfeb) — Master regulator of lysosomal biogenesis\n- [TFE3](/entities/tfe3) — Related transcription factor\n- [TFEC](/genes/tfec) — Microglia-enriched transcription factor (created today)\n- [TYROBP](/entities/tyrobp) — ITAM adaptor protein\n- [TREM2](/proteins/trem2-protein) — Microglial receptor\n\n### Related Mechanisms\n\n- [Microglial Activation](/mechanisms/microglial-activation)\n- [Lysosomal Dysfunction](/mechanisms/lysosomal-dysfunction-parkinsons)\n- [TREM2 Microglial Pathway](/mechanisms/trem2-microglial-pathway)\n- [Disease-Associated Microglia](/mechanisms/disease-associated-microglia)\n\n### Disease Pages\n\n- [Alzheimer's Disease](/diseases/alzheimers-disease)\n- [Parkinson's Disease](/diseases/parkinsons-disease)\n## References\n\n: [Pomeshchikov Y et al. Beyond MITF: bHLH transcription factors in melanoma and neurodegeneration. Nat Rev Cancer (2020)](https://doi.org/10.1038/s41568-020-00308-8)\n: [Martina JA et al. The TFEB transcription factor regulates autophagy and lysosomal genes. Nat Cell Biol (2014)](https://doi.org/10.1038/ncb2912)\n: [Martina JA et al. MITF controls the lysosomal and autophagic pathway in microglia. Autophagy (2016)](https://doi.org/10.1080/15548627.2016.1191735)\n: [Hamilton A et al. TREM2 and microglia in neurodegeneration: the nuclear perspective. Trends Neurosci (2019)](https://doi.org/10.1016/j.tins.2019.08.003)\n\n## See Also\n\n- TFEB Transcription Factor\n- TFE3 Transcription Factor\n- TFEC Gene\n- [TREM2 Protein](/proteins/trem2-protein)\n- [TYROBP Protein](/proteins/tyrobp-protein)\n- Microglial Activation Mechanisms\n- Lysosomal Dysfunction in PD\n\n## Related Hypotheses\n\n*From the [SciDEX Exchange](/exchange) — scored by multi-agent debate*\n\n- [TREM2-Dependent Microglial Senescence Transition](/hypothesis/h-61196ade) — <span style=\"color:#81c784;font-weight:600\">0.76</span> · Target: TREM2\n- [Cell-Type Specific TREM2 Upregulation in DAM Microglia](/hypothesis/h-seaad-51323624) — <span style=\"color:#81c784;font-weight:600\">0.70</span> · Target: TREM2\n- [APOE-TREM2 Interaction Modulation](/hypothesis/h-180807e5) — <span style=\"color:#81c784;font-weight:600\">0.66</span> · Target: TREM2\n- [TREM2-Mediated Selective Aggregate Clearance Pathway](/hypothesis/h-3460f820) — <span style=\"color:#81c784;font-weight:600\">0.63</span> · Target: TREM2\n- [TREM2 Conformational Stabilizers for Synaptic Discrimination](/hypothesis/h-044ee057) — <span style=\"color:#ffd54f;font-weight:600\">0.58</span> · Target: TREM2\n- [TREM2-mediated microglial tau clearance enhancement](/hypothesis/h-b234254c) — <span style=\"color:#ffd54f;font-weight:600\">0.55</span> · Target: TREM2\n- [CYP46A1 Overexpression Gene Therapy](/hypothesis/h-2600483e) — <span style=\"color:#81c784;font-weight:600\">0.79</span> · Target: CYP46A1\n- [APOE-TREM2 Interaction Modulation](/hypothesis/h-180807e5) — <span style=\"color:#81c784;font-weight:600\">0.66</span> · Target: TREM2\n\n\n**Related Analyses:**\n- [Neuroinflammation resolution mechanisms and pro-resolving mediators](/analysis/SDA-2026-04-01-gap-014) &#x1f504;\n- [Lipid raft composition changes in synaptic neurodegeneration](/analysis/SDA-2026-04-01-gap-lipid-rafts-2026-04-01) &#x1f504;\n- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v5-20260402) &#x1f504;\n",
  "entity_type": "gene"
}
  4. v1
    Content snapshot 
    {
  "content_md": "# MITF Gene\n\n<table class=\"infobox infobox-gene\">\n  <tr>\n    <th class=\"infobox-header\" colspan=\"2\">MITF Gene</th>\n  </tr>\n  <tr>\n    <td class=\"label\">Gene Symbol</td>\n    <td>MITF</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Full Name</td>\n    <td>Microphthalmia-Associated Transcription Factor</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Chromosome</td>\n    <td>3p13</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Protein Family</td>\n    <td>bHLH-Zip (MITF/TFEB/TFE3/TFEC)</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Primary Expression</td>\n    <td>Melanocytes, microglia, retinal pigment epithelium</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Function</td>\n    <td>Lysosomal biogenesis, phagocytosis, melanogenesis</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Isoform</td>\n    <td>Expression</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF-A</td>\n    <td>Ubiquitous</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF-M</td>\n    <td>Melanocytes</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF-H</td>\n    <td>Heart</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF-B</td>\n    <td>Brain</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Approach</td>\n    <td>Rationale</td>\n  </tr>\n  <tr>\n    <td class=\"label\">MITF agonists</td>\n    <td>Boost microglial phagocytosis</td>\n  </tr>\n  <tr>\n    <td class=\"label\">TREM2-MITF axis</td>\n    <td>Combined targeting</td>\n  </tr>\n  <tr>\n    <td class=\"label\">AAV-MITF</td>\n    <td>Gene therapy</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Factor</td>\n    <td>MITF</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Microglial expression</td>\n    <td>High</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Lysosomal genes</td>\n    <td>Yes</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Melanocyte link</td>\n    <td>Yes</td>\n  </tr>\n  <tr>\n    <td class=\"label\">TREM2 crosstalk</td>\n    <td>Yes</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Associated Diseases</td>\n    <td><a href=\"/wiki/aging\" style=\"color:#ef9a9a\">Aging</a>, <a href=\"/wiki/als\" style=\"color:#ef9a9a\">Als</a>, <a href=\"/wiki/cancer\" style=\"color:#ef9a9a\">Cancer</a>, <a href=\"/wiki/carcinoma\" style=\"color:#ef9a9a\">Carcinoma</a>, <a href=\"/wiki/colorectal-cancer\" style=\"color:#ef9a9a\">Colorectal Cancer</a></td>\n  </tr>\n  <tr>\n    <td class=\"label\">KG Connections</td>\n    <td><a href=\"/atlas\" style=\"color:#4fc3f7\">200 edges</a></td>\n  </tr>\n</table>\n\n## Overview\n\n## Gene Structure and Function\n\n**MITF (Microphthalmia-Associated Transcription Factor)** is a lineage-specific transcription factor of the bHLH-Zip family that controls cellular differentiation, proliferation, and function in melanocytes, retinal pigment epithelium, and microglia. While best known for its role in melanoma, MITF plays crucial roles in microglial function relevant to neurodegenerative diseases.\n\n### Structural Features\n\nMITF shares the bHLH-Zip structure with other family members:\n\n- **N-terminal transactivation domain**: Regulates transcriptional activity\n- **Basic helix-loop-helix domain**: DNA binding to E-box motifs (CANNTG)\n- **Leucine zipper dimerization domain**: Forms homo- and heterodimers\n- **Multiple isoforms**: Generated via alternative promoter usage and splicing\n\n### Isoforms\n\n## Role in Microglia\n\n### Lysosomal Biogenesis\n\nLike its siblings TFEB and TFE3, MITF drives expression of lysosomal and autophagic genes in microglia. The Martina et al. (2016) study demonstrated MITF's role in controlling the lysosomal-autophagy pathway in microglial cells. [@martina2016]\n\n### Phagocytosis Regulation\n\nMITF regulates genes involved in microglial phagocytosis:\n\n- **TREM2** signaling crosstalk\n- **CD68** (phagocytic marker)\n- **Integrin signaling** for particle engulfment\n- ** actin cytoskeleton** remodeling\n\n### Inflammatory Response\n\nMITF modulates microglial inflammatory responses through regulation of:\n\n- Cytokine expression\n- Complement system components\n- Antigen presentation molecules\n\n## Relationship to TREM2-TYROBP Signaling\n\nMITF operates in a shared pathway with TREM2 and TYROBP:\n\n```mermaid\nflowchart TD\n    A[\"TREM2 Activation<br/>Ligand binding\"] --> B[\"TYROBP/DAP12<br/>ITAM signaling\"]\n    B --> C[\"SYK Activation\"]\n    C --> D{\"Transcription Factor<br/>Activation\"}\n\n    D --> E[\"MITF Activation\"]\n    D --> F[\"TFEB/TFE3 Activation\"]\n    D --> G[\"TFEC Activation\"]\n\n    E --> H[\"Microglial Gene Expression\"]\n    F --> H\n    G --> H\n\n    H --> I[\"Enhanced Phagocytosis\"]\n    H --> J[\"Lysosomal Biogenesis\"]\n    H --> K[\"Inflammatory Modulation\"]\n```\n\nThis signaling axis is critical for microglial responses in AD and PD.\n\n## Relevance to Neurodegenerative Diseases\n\n### Alzheimer's Disease\n\nIn AD, MITF plays important roles:\n\n1. **Microglial phagocytosis**: MITF maintains efficient amyloid-beta clearance\n2. **TREM2 pathway**: Shares signaling with protective TREM2 variants\n3. **Lysosomal function**: Supports autophagic-lysosomal degradation\n\n### Parkinson's Disease\n\nMITF involvement in PD relates to:\n\n1. **Alpha-synuclein clearance**: MITF-driven autophagy helps clear aggregates\n2. **Microglial activation**: Modulates neuroinflammatory responses\n3. **Lysosomal health**: Supports microglial degradation capacity\n\n### Therapeutic Potential\n\n### Comparison with TFEB/TFE3/TFEC\n\n## Cross-Linking\n\n### Related Genes\n\n- [TFEB](/entities/tfeb) — Master regulator of lysosomal biogenesis\n- [TFE3](/entities/tfe3) — Related transcription factor\n- [TFEC](/genes/tfec) — Microglia-enriched transcription factor (created today)\n- [TYROBP](/entities/tyrobp) — ITAM adaptor protein\n- [TREM2](/proteins/trem2-protein) — Microglial receptor\n\n### Related Mechanisms\n\n- [Microglial Activation](/mechanisms/microglial-activation)\n- [Lysosomal Dysfunction](/mechanisms/lysosomal-dysfunction-parkinsons)\n- [TREM2 Microglial Pathway](/mechanisms/trem2-microglial-pathway)\n- [Disease-Associated Microglia](/mechanisms/disease-associated-microglia)\n\n### Disease Pages\n\n- [Alzheimer's Disease](/diseases/alzheimers-disease)\n- [Parkinson's Disease](/diseases/parkinsons-disease)\n## References\n\n: [Pomeshchikov Y et al. Beyond MITF: bHLH transcription factors in melanoma and neurodegeneration. Nat Rev Cancer (2020)](https://doi.org/10.1038/s41568-020-00308-8)\n: [Martina JA et al. The TFEB transcription factor regulates autophagy and lysosomal genes. Nat Cell Biol (2014)](https://doi.org/10.1038/ncb2912)\n: [Martina JA et al. MITF controls the lysosomal and autophagic pathway in microglia. Autophagy (2016)](https://doi.org/10.1080/15548627.2016.1191735)\n: [Hamilton A et al. TREM2 and microglia in neurodegeneration: the nuclear perspective. Trends Neurosci (2019)](https://doi.org/10.1016/j.tins.2019.08.003)\n\n## See Also\n\n- TFEB Transcription Factor\n- TFE3 Transcription Factor\n- TFEC Gene\n- [TREM2 Protein](/proteins/trem2-protein)\n- [TYROBP Protein](/proteins/tyrobp-protein)\n- Microglial Activation Mechanisms\n- Lysosomal Dysfunction in PD\n\n## Related Hypotheses\n\n*From the [SciDEX Exchange](/exchange) — scored by multi-agent debate*\n\n- [TREM2-Dependent Microglial Senescence Transition](/hypothesis/h-61196ade) — <span style=\"color:#81c784;font-weight:600\">0.76</span> · Target: TREM2\n- [Cell-Type Specific TREM2 Upregulation in DAM Microglia](/hypothesis/h-seaad-51323624) — <span style=\"color:#81c784;font-weight:600\">0.70</span> · Target: TREM2\n- [APOE-TREM2 Interaction Modulation](/hypothesis/h-180807e5) — <span style=\"color:#81c784;font-weight:600\">0.66</span> · Target: TREM2\n- [TREM2-Mediated Selective Aggregate Clearance Pathway](/hypothesis/h-3460f820) — <span style=\"color:#81c784;font-weight:600\">0.63</span> · Target: TREM2\n- [TREM2 Conformational Stabilizers for Synaptic Discrimination](/hypothesis/h-044ee057) — <span style=\"color:#ffd54f;font-weight:600\">0.58</span> · Target: TREM2\n- [TREM2-mediated microglial tau clearance enhancement](/hypothesis/h-b234254c) — <span style=\"color:#ffd54f;font-weight:600\">0.55</span> · Target: TREM2\n- [CYP46A1 Overexpression Gene Therapy](/hypothesis/h-2600483e) — <span style=\"color:#81c784;font-weight:600\">0.79</span> · Target: CYP46A1\n- [APOE-TREM2 Interaction Modulation](/hypothesis/h-180807e5) — <span style=\"color:#81c784;font-weight:600\">0.66</span> · Target: TREM2\n\n\n**Related Analyses:**\n- [Neuroinflammation resolution mechanisms and pro-resolving mediators](/analysis/SDA-2026-04-01-gap-014) &#x1f504;\n- [Lipid raft composition changes in synaptic neurodegeneration](/analysis/SDA-2026-04-01-gap-lipid-rafts-2026-04-01) &#x1f504;\n- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v5-20260402) &#x1f504;\n",
  "entity_type": "gene"
}